Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Process Devised for Continuous Stem Cell Production

Researchers in the U.K. developed a process for closed-loop continuous production and collection of large quantities of stem cells for therapies. . . . → Read More: Process Devised for Continuous Stem Cell Production

Biotech Licenses Mayo Clinic Microbiome Research

A biotechnology company developing therapies with specialized gut microbes is licensing research from the Mayo Clinic on these microbes’ effects with autoimmune diseases. . . . → Read More: Biotech Licenses Mayo Clinic Microbiome Research

Trial Underway Testing Personal RNA Cancer Drug

A clinical trial is underway testing a treatment for solid tumor cancers derived from messenger RNA, genetic material with protein coding instructions for cells. . . . → Read More: Trial Underway Testing Personal RNA Cancer Drug

Two Opioid Addiction Treatments Found Safe, Effective

A clinical trial testing two leading therapies for opioid abuse found the treatments both safe and effective, even though they work in different ways. . . . → Read More: Two Opioid Addiction Treatments Found Safe, Effective

Alliance Exploring Microbiome on Cancer Immunotherapy

A biotechnology company and two research institutes are collaborating on a study of a proposed cancer treatment that targets the microbiome, communities of bacteria in the human body. . . . → Read More: Alliance Exploring Microbiome on Cancer Immunotherapy

FDA Clears First Sensor-Pill and App System

The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence. . . . → Read More: FDA Clears First Sensor-Pill and App System

Zymeworks, Janssen in $1.45B Antibody Licensing Deal

Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets. . . . → Read More: Zymeworks, Janssen in $1.45B Antibody Licensing Deal

Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system. . . . → Read More: Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Open-Source Model Devised to Value Medical Technologies

An initiative joining most major health care stakeholders is developing models to calculate the value of medical treatments, with a process described as open and transparent. . . . → Read More: Open-Source Model Devised to Value Medical Technologies

New Finance, Development Model for Pancreatic Disease

An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis. . . . → Read More: New Finance, Development Model for Pancreatic Disease